TradeFlare's AI research teams analysed DSGN on 4 market nights between June 23, 2026 and July 16, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 16, 2026 | HOLD | $13.52 | — / — | -7.8% | +14.1% | Positive clinical trial developments for Friedreich's ataxia. |
| June 25, 2026 | BUY | $13.78 | — / — | +16.4% | -12.3% | Promising clinical trial data for Friedreich's ataxia. |
| June 24, 2026 | BUY | $13.74 | $16.50 / $11.68 | +6.4% | -15.6% | The post-earnings drift pattern suggests a sustained upward move over the coming weeks. |
| June 23, 2026 | HOLD | $13.70 | — / — | +5.3% | -14.3% | Positive clinical trial results for Friedreich's Ataxia. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.